Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-01-09 @ 10:34 AM
Study NCT ID:
NCT02775851
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-02
First Post:
2016-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-05-15
Completion Date Type:
ESTIMATED
First Submit Date:
2016-05-16
First Submit QC Date:
None
Study First Post Date:
2016-05-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-02-16
Results First Submit QC Date:
None
Results First Post Date:
2024-04-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-12-02
Last Update Post Date Type:
ESTIMATED